This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/06/15 - 3:59:45 PM ET (BATS BZX Real-time Price)
Div Yield: --
NLNK Day's Range
NLNK 52 Week Range
NLNK Business Summary
NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer.View NLNK key stats
NewLink Genetics Corp - NLNK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates NewLink Genetics Corp as a
Hold with a ratings score of C.
Report Snippet: We rate NEWLINK GENETICS CORP (NLNK) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the company's profit margins have been poor overall.